Skip to main content

Together we are beating cancer

Donate now

News

Showing 12 out of 2996 results
Prostate cancer cells
  • Science & Technology
  • Health & Medicine

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

by Cancer Research UK | News | 19 September 2021

19 September 2021

A microscopy image showing ball of prostate cells expressing a potential new marker (red) for aggressive prostate cancer.

Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option. Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option.

by Cancer Research UK | News | 14 September 2021

14 September 2021

Cigarette in ashtray

Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown. Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown.

by Cancer Research UK | News | 25 August 2021

25 August 2021

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

by Cancer Research UK | News | 24 August 2021

24 August 2021

  • Health & Medicine
  • Science & Technology

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

by Cancer Research UK | News | 13 August 2021

13 August 2021

3D rendering of oesophageal cancer

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

by Harry Jenkins | News | 11 August 2021

11 August 2021

Clinician holds hand of patient on hospital bed.

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.

by Cancer Research UK | News | 5 August 2021

5 August 2021